Pay in 4 interest-free payments of $7.49 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
282 Clinical exploration of Inotersen in ATTR-CM is still in progress, with a phase 2 trial (NCT03702829) underway
Each may serve different patient preferences and clinical scenarios
Epicardial fat expansion in diabetic and obese patients with heart failure and preserved ejection fraction-A specific HFpEF phenotype
Molecular characterization of the orphan transporter SLC16A9, an extracellular pH- and Na(+)-sensitive creatine transporter
Appetite suppression typically intensifies during weeks 5-12 as your dose increases according to the prescribed titration schedule
US$ 25.13
US$ 20.15
US$ 21.06
US$ 24.28
US$ 20.07
US$ 29.15
